Biotech Snap
Login
Subscribe
Biotech Snap
Archive
Page 0
Latest news
15 hours ago
Renasant Bio launches with $54.5M to tackle rare kidney disease
Joachim Eeckhout
Jul 10, 2025
AbbVie pays $700 million upfront for a trispecific antibody from Ichnos Glenmark Innovation
Joachim Eeckhout
Jul 10, 2025
Actithera lands $75.5M to chase next-gen cancer radiopharma
Joachim Eeckhout
Jul 09, 2025
Merck bets $10B on COPD breakthrough with Verona Pharma buyout
Joachim Eeckhout
Jul 09, 2025
Concentra snaps up troubled Cargo Therapeutics in latest biotech acquisition
Joachim Eeckhout
Jul 09, 2025
ProKidney’s cell therapy shows promise in chronic kidney disease trial
Joachim Eeckhout
Jul 08, 2025
Cogent challenges Blueprint Medicines’ Ayvakit with strong trial data for rare immune disease
Joachim Eeckhout
Jul 08, 2025
Early trial data backs AstraZeneca's $1B bet on EsoBiotec’s CAR-T therapy
Joachim Eeckhout
Jul 07, 2025
Boston biotech industry is under pressure due to a funding drought and Trump's policy
Joachim Eeckhout
Jul 04, 2025
MaaT Pharma partners with Clinigen to launch Europe’s first microbiome therapy for aGvHD
Joachim Eeckhout
Jul 03, 2025
Vyne's BET inhibitor ends psoriasis trial after FDA hold
Joachim Eeckhout
Jul 03, 2025
Biokin scores phase 3 win for BMS backed bispecific ADC
Joachim Eeckhout
First
Back
1
2
3
Next
Last